[New therapeutic approaches for dyslipidemias].
Vergès
Bruno
B
Service endocrinologie, diabétologie et maladies métaboliques, Hôpital du Bocage, CHU de Dijon. bruno.verges@chu-dijon.fr
D002784:Cholesterol / Q000378:metabolism; D050171:Dyslipidemias / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D007408:Intestinal Absorption; D043884:Receptor, Cannabinoid, CB1 / Q000037:antagonists & inhibitors
D007004:Hypoglycemic Agents; D000960:Hypolipidemic Agents; D043884:Receptor, Cannabinoid, CB1; D002784:Cholesterol